Locations:
Search IconSearch
October 18, 2015/Cancer/News & Insight

New Cleveland Clinic Software Boosts Process Consistency in Radiation Oncology

Signals alert to potential process deviations

ASTRO_690x380

Process consistency is essential, but sometimes elusive in radiation oncology. It improves the quality of treatment, reduces errors and raises overall efficiency. To improve consistency in the process of planning and delivery of radiation therapy, Cleveland Clinic has designed a new software program, the Quantitative Metrics and Automatic Auditing Program, or QMAP.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Yu_Nalchang_inset

The program is based on a set of quantitative metrics that rate the timely completion of critical clinical tasks, as defined internally by the Department of Radiation Oncology. QMAP generates alerts or reminders that are very effective in keeping clinicians on schedule with key tasks.

“We believe that consistency in the planning and delivery of radiation therapy is essential to maintain treatment quality, patient safety and efficiency,” says Naichang Yu, PhD, an associate staff member in the department and one of the programs’ designers. Dr. Yu is also lead author of a study of the effectiveness of QMAP, results of which were presented at the 2015 annual meeting of the American Society for Radiology Oncology (ASTRO) in San Antonio, Texas.

Alerts give clinicians time to avoid potential deviations

QMAP software automatically captures the historical trend of each metric and provides daily alerts for potential deviations (i.e., misses) from defined processes, based on Cleveland Clinic’s electronic medical record (EMR) system. Alerts are directed to triage teams within a timeframe that gives clinicians the opportunity to avoid the deviations.

The three key tasks targeted by the department and the software are:

1. Complete the radiation therapy planning process at least four hours prior to the scheduled treatment time for non-emergency patients.
2. Review patient cone-beam computed tomography (CBCT) images the same day they become available.
3. Complete visits to patients (by physicians) in a timely fashion, according to a department-defined schedule.

Advertisement

On average, 120 patients a day were treated by external beam radiotherapy in the department throughout the course of the study.

Study results show marked improvement in compliance

“Our internally defined goals are established above and beyond accepted industry practice standards,” Dr. Yu says. “The study demonstrated significant improvement in our compliance rate in the three metrics we studied.”

As an example, for non-emergency patients undergoing external beam radiation therapy, the planning process was completed at least four hours prior to the scheduled treatment time 96 percent of the time in December 2014, an increase from 86 percent in January 2011. “This increased compliance was well sustained throughout the period that these measures were in place,” Dr. Yu says.
In a second example, Dr. Yu notes that during the study period, the rate that physician visits were completed within the departmental-defined schedule increased from 94 percent to more than 99 percent.
The third metric studied was the timely image review rate. During the study period, the rate patient images were reviewed on the same day of acquisition increased from 91 percent to a sustained over 99 percent, says Dr. Yu.

Quantifying QMAP’s efficacy based on patient outcomes

“Timely and quality completion of every step of care preparation and delivery can improve treatment quality and patient safety. It may also improve clinical practice efficiency,” says Dr. Yu.

The abstract describing the QMAP initiative further notes that this process improvement reduces the potential for errors resulting from distractions, interruptions and hurried attempts to complete critical tasks.

Advertisement

In the future, Dr. Yu concludes, “Quantitative demonstration of the correlation between compliance and clinical outcomes, such as reduction of medical errors and improved clinical efficiency, will be important.”

Advertisement

Related Articles

Doctors working on MGUS screening study
March 18, 2024/Cancer/Research
Pilot Study Aims for Early Identification of Multiple Myeloma Precursor Among Black Patients

First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses

Hematologist at Cleveland Clinic
March 14, 2024/Cancer/Blood Cancers
Advances in Mantle Cell Lymphoma Treatment (Podcast)

Global R&D efforts expanding first-line and relapse therapy options for patients

Physician with patient
March 6, 2024/Cancer/Research
Targeting Uncontrolled Erythrocytosis in Polycythemia Vera with Rusfertide

Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels

Dr. Jagadeesh at Cleveland Clinic
February 28, 2024/Cancer/Blood Cancers
Treating Patient with Systemic T-Cell Lymphoma and Graft-Versus-Host Disease

A case study on the value of access to novel therapies through clinical trials

Doctor measuring patient's waist size
February 26, 2024/Cancer/Research
Impact of Obesity on GVHD & Transplant Outcomes in Hematologic Malignancies

Findings highlight an association between obesity and an increased incidence of moderate-severe disease

Physician with patient
February 21, 2024/Cancer/Research
Strategies for Improving Clinical Trial Equity

Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456

How antibody drug conjugates work
February 13, 2024/Cancer/Research
Real-World Use of Trastuzumab Deruxtecan

Key learnings from DESTINY trials

CQD-4445459-rotz-650×450
February 7, 2024/Cancer
Advances in Bone Marrow Transplant Have Improved Outcomes in Fanconi Anemia

Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients

Ad